DPIIT recognised startup Government of India
Startup India
Renwik Bioinnovations Private Limited
Renwik Bioinnovations Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.33 Cr
▲ 61% YoY
Net profit · FY 2025
₹65,419
Net margin 0.5%
EBITDA · FY 2025
₹1.53 Lakh
EBITDA margin 1.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Renwik Bioinnovations Private Limited
Data last updated:
Renwik Bioinnovations Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73200DL2019PTC358147. Its GSTIN is 07AAJCR9394Q1Z6 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikash Kumar and Chandan Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at U – 41 Upadhyay Block Shakarpur, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹65,419 (net margin 0.5%) and EBITDA of ₹1.53 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 56% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
Renwik Bioinnovations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0002600).
Company details
CIN U73200DL2019PTC358147
Registration Number 358147
Incorporation Date 28 November 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0002600
Key People
Vikash Kumar Director Chandan Kumar Director Recognitions & Rankings of Renwik Bioinnovations
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0002600
Contact details
Renwik Bioinnovations Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressU – 41 Upadhyay Block Shakarpur, Delhi, India – 110092
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Renwik Bioinnovations Private Limited, buy the company report.
Comprehensive company report
Renwik Bioinnovations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Renwik Bioinnovations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Renwik Bioinnovations Private Limited, buy the company report.
Financials of Renwik Bioinnovations Private Limited
FY 2024 filings availableRenwik Bioinnovations Private Limited reported revenue of ₹1.33 Cr (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹1.33 Cr ▲ 61%
Net profit · FY 2025
₹65,419 margin 0.5%
EBITDA · FY 2025
₹1.53 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 37%
5 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 42%
5 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 56% over five years, including 61% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65,419 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Renwik Bioinnovations Private Limited, buy the company report.
Board of directors of Renwik Bioinnovations Private Limited
Renwik Bioinnovations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikash Kumar | Director | 26 Mar 2022 | 4 Years 6 Months | Current |
| Chandan Kumar | Director | 28 Nov 2019 | 6 Years 10 Months | Current |
Auditor
Renwik Bioinnovations Private Limited is audited by RAJIV K SINGH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV K SINGH | FY 2023 | 517609 |
Shareholding
The shareholding of Renwik Bioinnovations Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Renwik Bioinnovations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Dec 2022 | 100679784 | Canara Bank | ₹8 Lakh | Open |
To see the full charge records of Renwik Bioinnovations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Renwik Bioinnovations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Renwik Bioinnovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Renwik Bioinnovations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCR9394Q1Z6 | Delhi | Active | 12 Dec 2019 |
To see the full GST registrations and return filing status of Renwik Bioinnovations Private Limited, buy the company report.
Recent activity
Renwik Bioinnovations Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Kuldeep Dwivedi ceased to be Director on 26 Mar 2022.
AGM
Renwik Bioinnovations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Renwik Bioinnovations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Canara Bank of Rs. 8.00 Lakh registered on 26 Dec 2022 with Charge ID 100679784 was modified on 21 Feb 2024.
Charges
A charge with Canara Bank amounted to Rs. 8.00 Lakh with Charge ID 100679784 was registered on 26 Dec 2022.
Ceased
Kuldeep Dwivedi ceased to be Director.
Appointed
Vikash Kumar was appointed as Director.
Appointed
Chandan Kumar was appointed as Director.
Incorporation
28 Nov 2019
Renwik Bioinnovations Private Limited was registered on 28 Nov 2019 with Roc Delhi & aged 6 years 10 months as per MCA records.
Frequently asked questions
Renwik Bioinnovations is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 28 November 2019 (7+ years old) and is registered under CIN U73200DL2019PTC358147.
Renwik Bioinnovations has 2 current directors:
- Vikash Kumar - Director
- Chandan Kumar - Director
The latest financial statements of Renwik Bioinnovations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Renwik Bioinnovations is 07AAJCR9394Q1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Renwik Bioinnovations is U73200DL2019PTC358147. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Renwik Bioinnovations was incorporated on 28 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Kuldeep Dwivedi ceased to be Director on 26 Mar 2022. Vikash Kumar was appointed as Director on 26 Mar 2022. Chandan Kumar was appointed as Director on 28 Nov 2019.
Yes, Renwik Bioinnovations is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Renwik Bioinnovations is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0002600).
The registered office of Renwik Bioinnovations is at U – 41 Upadhyay Block Shakarpur, Delhi, India – 110092.